18-JUN-2026 6:10

LYMPH ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S1918-DLBCL, Adv, Age 75+, CC-486 +/- R-miniCHOP 1 T 1 CC-486 + R-miniCHOP 422 69 0 0 0 0 0 05/25/2021 197 60
        2 R-miniCHOP   67 0 0 0 0 0      
            136 0 0 0 0 0      
 
  S2114-NHL, Rel/Ref, CD19 CAR-T +/- Consolidation 1 Y 0 CD19 CAR T-cell Therapy 396 230 87 51 31 10 1 06/12/2023 134 43
            230 87 51 31 10 1      
 
    2 Y 1 Mosunetuzumab   13 5 4 3 2 1 06/12/2023    
        2 Polatuzumab   12 4 2 1 1 0      
        3 Mosunetuzumab + Polatuzumab   11 3 2 1 0 0      
        4 Observation   12 5 2 2 1 1      
            48 17 10 7 4 2      
 
    3 Y 5 Mosunetuzumab + Polatuzumab   4 1 0 0 0 0 06/12/2023    
            4 1 0 0 0 0      
 
  S2207-LBCL, Transplant Inelig, Targeted Tx + Tafa 1 T 1 Tazemetostat (Arm 1) Dose Level 1 241 7 0 0 0 0 0 09/26/2023 142 40
        10 Tazemetostat (Arm 1) Dose Level 1   6 6 0 0 0 0      
        11 Tazemetostat (Arm 1) Dose Level 2   5 5 5 0 0 0      
        13 Zanubrutinib (Arm 3) Dose Level 2   1 1 0 0 0 0      
        4 Zanubrutinib (Arm 3) Dose Level 1   10 0 0 0 0 0      
        5 Zanubrutinib (Arm 3) Dose Level 2   10 0 0 0 0 0      
            39 12 5 0 0 0      
 
  S2308-FL, LTB, Mosunetuzumab vs Rituximab 1 Y 1 Rituximab 600 182 123 66 44 13 3 10/23/2024 261 90
        2 Mosunetuzumab   180 121 68 41 14 2      
            362 244 134 85 27 5      
 
Yes A051902-PTCL,CHO(E)PvCC-486-CHO(E)PvDuvelisib-CHO(E)P 1 E Total Registrations   19 2 0 0 0 0 10/14/2023 227 80
            19 2 0 0 0 0      
 
  A052101-Lymph, Stg I-IV, Cont v Intermittent Zanub 1 E Total Registrations   34 15 8 2 0 0 01/03/2024 226 77
            34 15 8 2 0 0      
 
    2 E Total Registrations   16 6 3 2 2 1 01/03/2024    
            16 6 3 2 2 1      
 
  AHOD2131-cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy 1 E Total Registrations   105 47 25 14 5 2 08/15/2023 331 132
            105 47 25 14 5 2      
 
    2 E Total Registrations   92 46 24 12 6 1 08/15/2023    
            92 46 24 12 6 1      
 
No EA4231-Lymph, DL B-Cell, Ven+Ib+Pred+Ob+Rev 1 E Total Registrations   1 1 1 1 0 0 03/30/2026 35 8
            1 1 1 1 0 0      
 
  EA4232-Lymph, Peri T Cell, Auto Stem 1 E Total Registrations   2 2 1 0 0 0 09/15/2025 50 14
            2 2 1 0 0 0